
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.320 | 1.530 | 0.210 |
Stocks | 98.680 | 98.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.562 | 17.636 |
Price to Book | 2.960 | 3.332 |
Price to Sales | 1.960 | 2.172 |
Price to Cash Flow | 13.566 | 13.989 |
Dividend Yield | 3.262 | 2.941 |
5 Years Earnings Growth | 17.739 | 13.407 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 33.940 | 30.818 |
Financial Services | 28.990 | 21.205 |
Industrials | 12.720 | 16.339 |
Consumer Defensive | 12.110 | 12.527 |
Technology | 4.660 | 3.471 |
Consumer Cyclical | 4.020 | 5.344 |
Communication Services | 2.690 | 2.897 |
Basic Materials | 0.870 | 8.342 |
Number of long holdings: 44
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 9.34 | 86.80 | +0.49% | |
Novartis | CH0012005267 | 9.20 | 90.46 | +0.29% | |
Roche Holding Participation | CH0012032048 | 9.09 | 254.40 | -0.39% | |
Zurich Insurance Group | CH0011075394 | 8.35 | 558.40 | +0.87% | |
Swiss Re | CH0126881561 | 4.96 | 140.15 | +0.25% | |
ABB | CH0012221716 | 4.89 | 41.60 | -0.41% | |
UBS Group | CH0244767585 | 4.89 | 22.96 | -1.03% | |
Lonza Group | CH0013841017 | 4.36 | 541.60 | +0.18% | |
Swiss Life Holding | CH0014852781 | 3.93 | 780.20 | +0.57% | |
Alcon | CH0432492467 | 3.58 | 75.74 | +0.50% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Strategy Fund Yield CHF K 1 acc | 1.44B | 2.30 | -0.78 | 0.66 | ||
UBS Strategy Fund Growth CHF Q acc | 593.05M | 4.07 | 1.00 | 3.39 | ||
UBS Equity S European High Dividend | 146.67M | 8.57 | 5.50 | 2.20 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review